XML 97 R19.htm IDEA: XBRL DOCUMENT
v3.20.1

Employee Benefit Plans | 9 Months Ended
--- | ---
Mar. 31, 2020
Share Based Compensation [Abstract] |
Employee Benefit Plans |
12. | Employee Benefit Plans
Shares Reserved for Issuance The Company had reserved for issuance as of the dates noted (in thousands):
|  | March 31, 2020 |  |  | June 30, 2019 |
2013 Equity Incentive Plan shares available for grant |  |  | 11,368 |  |  |  | 8,462 |
Employee stock options and awards outstanding |  |  | 12,086 |  |  |  | 10,455 |
2014 Employee Stock Purchase Plan |  |  | 7,364 |  |  |  | 10,085 |
Total shares reserved for issuance |  |  | 30,818 |  |  |  | 29,002 |
Aerohive 2014 Equity Incentive Plan Pursuant to the acquisition of Aerohive on August 9, 2019, the Company assumed the Aerohive 2014 Equity Incentive Plan (the "Aerohive Plan"). Stock awards outstanding under the Aerohive Plan were converted into awards for Extreme shares as of the Acquisition Date at a predetermined rate pursuant to the Merger Agreement. As of March 31, 2020, total awards to acquire 736,796 shares of Extreme common stock were outstanding under the Aerohive Plan. If a participant terminates employment prior to the vesting dates, the non-vested shares will be forfeited and retired. No future grants may be made from the Aerohive Plan. Share-based Compensation Expense Share-based compensation expense recognized in the condensed consolidated financial statements by line item caption is as follows (in thousands):
|  | Three Months Ended |  |  | Nine Months Ended |
|  | March 31, 2020 |  |  | March 31, 2019 |  |  | March 31, 2020 |  |  | March 31, 2019 |
Cost of product revenue |  | $ | 280 |  |  | $ | 223 |  |  | $ | 932 |  |  | $ | 618 |
Cost of service revenue |  |  | 368 |  |  |  | 648 |  |  |  | 1,220 |  |  |  | 1,670 |
Research and development |  |  | 2,518 |  |  |  | 2,814 |  |  |  | 8,213 |  |  |  | 7,953 |
Sales and marketing |  |  | 1,338 |  |  |  | 3,187 |  |  |  | 8,568 |  |  |  | 8,529 |
General and administrative |  |  | 2,639 |  |  |  | 1,942 |  |  |  | 7,523 |  |  |  | 5,569 |
Integration costs |  |  | — |  |  |  | — |  |  |  | 479 |  |  |  | — |
Total share-based compensation expense |  | $ | 7,143 |  |  | $ | 8,814 |  |  | $ | 26,935 |  |  | $ | 24,339 |
During the three and nine months ended March 31, 2020, and 2019, the Company did not capitalize any share-based compensation expense in inventory, as the amounts were immaterial. Stock Awards Stock awards may be granted under the 2013 Equity Incentive Plan (the “2013 Plan”) on terms approved by the Compensation Committee of the Board. Stock awards generally provide for the issuance of restricted stock units (“RSUs”) including performance or market-based RSUs which vest over a fixed period of time or based upon the satisfaction of certain performance criteria. The Company uses the straight-line method for expense attribution. The Company does not estimate forfeitures, but accounts for them as incurred. The following table summarizes stock award activity for the nine months ended March 31, 2020 (in thousands, except grant date fair value):
|  | Number of Shares |  |  | Weighted- Average Grant Date Fair Value |  |  | Aggregate Fair Market Value |
Non-vested stock awards outstanding at June 30, 2019 |  |  | 7,736 |  |  | $ | 7.67 |  |  |  |  |
Granted |  |  | 6,299 |  |  |  | 6.83 |  |  |  |  |
Released |  |  | (3,365 | ) |  |  | 7.11 |  |  |  |  |
Cancelled |  |  | (1,598 | ) |  |  | 7.28 |  |  |  |  |
Non-vested stock awards outstanding at March 31, 2020 |  |  | 9,072 |  |  | $ | 7.40 |  |  | $ | 28,033 |
Vested and expected to vest at March 31, 2020 |  |  | 6,397 |  |  | $ | 7.26 |  |  | $ | 25,947 |
The following table summarizes stock option activity for the nine months ended March 31, 2020 (in thousands, except per share and contractual term):
|  | Number of Shares |  |  | Weighted-Average Exercise Price Per Share |  |  | Weighted-Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value |
Options outstanding at June 30, 2019 |  |  | 2,719 |  |  | $ | 4.61 |  |  |  | 3.26 |  |  | $ | 5,070 |
Granted |  |  | 637 |  |  |  | 6.70 |  |  |  |  |  |  |  |  |
Exercised |  |  | (217 | ) |  |  | 4.58 |  |  |  |  |  |  |  |  |
Cancelled |  |  | (125 | ) |  |  | 6.02 |  |  |  |  |  |  |  |  |
Options outstanding at March 31, 2020 |  |  | 3,014 |  |  | $ | 4.99 |  |  |  | 3.39 |  |  | $ | 524 |
Vested and expected to vest at March 31, 2020 |  |  | 3,014 |  |  | $ | 4.99 |  |  |  | 3.39 |  |  | $ | 524 |
Exercisable at March 31, 2020 |  |  | 1,693 |  |  | $ | 3.78 |  |  |  | 1.43 |  |  | $ | 524 |
The fair value of each stock option grant under the 2013 Plan and 2005 Equity Incentive Plan is estimated on the date of grant using the Black-Scholes-Merton option valuation model. The Company uses the Monte-Carlo simulation model to determine the fair value and the derived service period of stock awards with market conditions, on the date of the grant. The expected term of options granted is derived from historical data on employee exercise and post-vesting employment termination behavior. The risk-free rate is based upon the estimated life of the option and the U.S. Treasury yield curve in effect at the time of grant. Expected volatility is based on the historical volatility on the Company’s stock. The average fair value per share of the options granted during the nine months ended March 31, 2020 was $6.70. The fair value of each RSU grant with performance-based vesting criteria (“PSUs”) under the 2013 Plan is estimated on the date of grant using the Monte-Carlo simulation model to determine the fair value and the derived service period of stock awards with market conditions, on the date of the grant. The RSUs granted during the nine months ended March 31, 2020 vest from the original grant date as to one-third (1/3) on the one-year anniversary and one-twelfth (1/12) each quarter thereafter, subject to continued service to the Company. These RSUs included 566,038 RSUs to named executive officers and directors. During fiscal 2019 and 2018, the Company approved the grant of 0.6 million shares underlying stock awards each year in the form of PSU’s to named executive officers and other vice president level employees. These PSUs would be considered earned once the Company’s U.S. GAAP earnings aggregates at least $0.20 per share over two consecutive quarters (the “Performance Thresholds”). During the second quarter of fiscal 2020, the compensation committee of the Board modified the Performance Thresholds of $0.20 earnings per share over two consecutive quarters for PSUs issued in fiscal 2019 and 2018, to $0.09 earnings per share over two consecutive quarters. Upon satisfying the Performance Thresholds, the PSUs will vest with respect to the same number of RSUs that have vested which were granted on the same date and thereafter will vest on the same schedule as the RSUs, subject to continued service to the Company. If the Performance Thresholds is not met by the third anniversary of the grant date for each award, that award is canceled. During the nine months ended March 31, 2020, the 2019 and 2018 Performance Thresholds for outstanding performance awards were not achieved. 2014 Employee Stock Purchase Plan The fair value of each share purchase option under the Company’s 2014 Employee Stock Purchase Plan (“ESPP”) is estimated on the date of grant using the Black-Scholes-Merton option valuation model with the weighted average assumptions noted in the following table. The expected term of the ESPP represents the term of the offering period of each option. The risk-free rate is based upon the estimated life and on the U.S. Treasury yield curve in effect at the time of grant. Expected volatility is based on the historical volatility on the Company’s stock. There were 1,498,155 and 1,499,042 shares issued under the ESPP during the three months ended March 31, 2020 and 2019, respectively. There were 2,721,699 and 2,779,750 shares issued under the ESPP during the nine months ended March 31, 2020 and 2019, respectively. The following assumptions were used to calculate the fair value of shares issued under the ESPP during the following periods:
|  | Employee Stock Purchase Plan |  |  | Employee Stock Purchase Plan |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | March 31, 2020 |  |  | March 31, 2019 |  |  | March 31, 2020 |  |  | March 31, 2019 |
Expected life |  | 0.5 years |  |  | 0.5 years |  |  | 0.5 years |  |  | 0.5 years |
Risk-free interest rate |  |  | 1.56 | % |  |  | 2.46 | % |  |  | 1.71 | % |  |  | 2.35 | %
Volatility |  |  | 43 | % |  |  | 75 | % |  |  | 43 | % |  |  | 70 | %
Dividend yield |  |  | — | % |  |  | — | % |  |  | — | % |  |  | — | %
The weighted-average fair value of shares issued under the ESPP during the nine months ended March 31, 2020 and 2019 was $1.90 and $2.71, respectively. The weighted-average fair value of shares issued under the ESPP during the three months ended March 31, 2020 and 2019 was $1.76 and $2.69, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration